Skip to main content
. 2016 Apr 7;17(4):522. doi: 10.3390/ijms17040522

Figure 8.

Figure 8

IL-17A differentially activates signaling pathways in pre-adipocytes and adipocytes. (A) The pre-adipocytes and adipocytes were treated without (time zero) or with 20 ng/mL IL-17A for 5, 15, 30, 60, and 120 min; proteins were assessed by Western blot analysis; GAPDH was probed for loading control; (B–E) quantification of the Western blot results in (A); data are mean ± standard error of the mean (SEM) of three independent experiments; a p < 0.05, compared to the untreated group of the pre-adipocytes; b p < 0.05, compared to the untreated group of the adipocytes.